GSA Capital Partners LLP boosted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 355.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,265 shares of the company’s stock after purchasing an additional 23,619 shares during the quarter. GSA Capital Partners LLP owned approximately 0.05% of HealthEquity worth $1,508,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the business. UBS Asset Management Americas Inc. increased its holdings in HealthEquity by 24.3% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 28,342 shares of the company’s stock worth $1,412,000 after purchasing an additional 5,544 shares during the period. Nicholas Investment Partners LP increased its holdings in shares of HealthEquity by 11.2% in the 2nd quarter. Nicholas Investment Partners LP now owns 137,171 shares of the company’s stock valued at $6,837,000 after acquiring an additional 13,848 shares during the last quarter. Rafferty Asset Management LLC purchased a new position in shares of HealthEquity in the 2nd quarter valued at about $848,000. New York State Common Retirement Fund increased its holdings in shares of HealthEquity by 5.0% in the 2nd quarter. New York State Common Retirement Fund now owns 159,277 shares of the company’s stock valued at $7,937,000 after acquiring an additional 7,622 shares during the last quarter. Finally, Laurion Capital Management LP purchased a new position in shares of HealthEquity in the 2nd quarter valued at about $439,000. Institutional investors own 90.97% of the company’s stock.

In related news, Director Frank Medici sold 23,649 shares of the business’s stock in a transaction dated Wednesday, July 5th. The stock was sold at an average price of $50.27, for a total value of $1,188,835.23. Following the completion of the sale, the director now directly owns 6,381 shares of the company’s stock, valued at $320,772.87. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Stephen Neeleman sold 8,500 shares of the business’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $50.83, for a total value of $432,055.00. Following the completion of the sale, the insider now directly owns 1,000 shares of the company’s stock, valued at $50,830. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,574,500 shares of company stock valued at $79,719,804. 19.00% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This report was first posted by Daily Political and is the property of of Daily Political. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.dailypolitical.com/2017/09/25/gsa-capital-partners-llp-buys-23619-shares-of-healthequity-inc-hqy.html.

HQY has been the topic of a number of recent analyst reports. Cantor Fitzgerald reiterated a “buy” rating and issued a $56.00 price objective on shares of HealthEquity in a report on Tuesday, August 29th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $61.00 price objective (up previously from $57.00) on shares of HealthEquity in a report on Monday, June 12th. Chardan Capital increased their price objective on HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a report on Wednesday, June 7th. Zacks Investment Research upgraded HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price objective on the stock in a report on Wednesday, July 12th. Finally, BidaskClub downgraded HealthEquity from a “buy” rating to a “hold” rating in a report on Monday, July 24th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eight have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $56.50.

HealthEquity, Inc. (NASDAQ HQY) opened at 47.35 on Monday. HealthEquity, Inc. has a 1-year low of $30.34 and a 1-year high of $54.95. The company’s 50-day moving average price is $44.62 and its 200-day moving average price is $46.01. The stock has a market cap of $2.86 billion, a P/E ratio of 70.25 and a beta of 1.75.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.14 by $0.13. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The business had revenue of $56.90 million for the quarter, compared to analysts’ expectations of $55.66 million. During the same quarter in the previous year, the firm posted $0.16 earnings per share. The company’s revenue was up 28.7% compared to the same quarter last year. Analysts predict that HealthEquity, Inc. will post $0.71 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.